Showing results (2311-2320 of 2,551) with videos related to
Sort By:
Pageof 256
Lancet (London, England)|September 28, 2011
Inequality in early childhood: risk and protective factors for early child developmentSusan P Walker, Theodore D Wachs, Sally Grantham-McGregor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant gliomaJohn G Kuhn, Susan M Chang, Patrick Y Wen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2017
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILEBrian M Alexander, Sujuan Ba, Mitchel S Berger, et al.Nature Communications|December 14, 2023
On the benefits of the tryptophan metabolite 3-hydroxyanthranilic acid in Caenorhabditis elegans and mouse agingHope Dang, Raul Castro-Portuguez, Luis Espejo, et al.Neuro-Oncology|April 25, 2020
Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatmentRaymond Y Huang, Robert J Young, Benjamin M Ellingson, et al.Infection|October 16, 2008
Sporadic and outbreak cases of melioidosis in southern Taiwan: clinical features and antimicrobial susceptibilityH-I Shih, Y-C Chuang, B M-H Cheung, et al.Journal of Clinical Epidemiology|March 23, 2021
Improving the utility of evidence synthesis for decision makers in the face of insufficient evidenceM Hassan Murad, Stephanie M Chang, Celia V Fiordalisi, et al.The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.Molecular Therapy. Nucleic Acids|November 30, 2016
Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem CellsPatrick C Lee, Brian Truong, Agustin Vega-Crespo, et al.Pageof 256